Cargando…
An Analysis of Major Target Deviations in Craniospinal Irradiation Treatment Plans for Patients With Intermediate-Risk Medulloblastoma Within a Phase 3 Clinical Trial (Children's Oncology Group Study ACNS0331)
PURPOSE: Craniospinal irradiation remains an essential and yet difficult part of the treatment of patients with medulloblastoma. Whereas technological advances offer promise of increased conformity, realiance on advanced technology is not without risk, and it remains critical to carefully delineate...
Autores principales: | Schiff, Joshua P., Lee, Yimei, Wang, Yu, Perkins, Stephanie M., Kessel, Sandy K., Fitzgerald, Thomas J., Larrier, Nicole A., Michalski, Jeff M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723303/ https://www.ncbi.nlm.nih.gov/pubmed/36483060 http://dx.doi.org/10.1016/j.adro.2022.101083 |
Ejemplares similares
-
QOL-20. IMPACT OF RADIATION DOSE AND VOLUME ON MEMORY FUNCTIONING IN CHILDREN WITH MEDULLOBLASTOMA: A REPORT FROM CHILDREN’S ONCOLOGY GROUP (COG) ACNS0331
por: Embry, Leanne, et al.
Publicado: (2020) -
RONC-27. PROTON THERAPY REDUCES DOSE TO CRITICAL CENTRAL NERVOUS SYSTEM STRUCTURES IN MEDULLOBLASTOMA: A DOSIMETRIC ANALYSIS OF CHILDREN’S ONCOLOGY GROUP (COG) ACNS0331
por: Deek, Matthew, et al.
Publicado: (2020) -
MBCL-15. IMPACT OF MOLECULAR SUBGROUPS ON OUTCOMES FOLLOWING RADIATION TREATMENT RANDOMIZATIONS FOR AVERAGE RISK MEDULLOBLASTOMA: A PLANNED ANALYSIS OF CHILDREN’S ONCOLOGY GROUP (COG) ACNS0331
por: Michalski, Jeff, et al.
Publicado: (2020) -
MEDB-69. Clinical and molecular meta-analysis of three major medulloblastoma clinical trials (ACNS0331, SJMB03, ACNS0332) uncovers novel strategies to improve risk-stratified therapy
por: Smith, Kyle S, et al.
Publicado: (2022) -
Preclinical Models of Craniospinal Irradiation for Medulloblastoma
por: Stripay, Jennifer L., et al.
Publicado: (2020)